Latest Articles
Danielle Collins Talks Health Battle And Retirement Visit The Up Coming Website (ufVLJO9Ewy) - Министерство иностранных дел Республики Беларусь
Danielle Collins Talks Health Battle And Retirement Visit The Up Coming Website (ufVLJO9Ewy) Министерство иностранных дел Республики Беларусь
Published: Feb. 27, 2026, 3:32 p.m.
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data - TipRanks
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data TipRanks
Published: Feb. 27, 2026, 3:24 p.m.
Advancing support for endometriosis and menstrual wellbeing - GOV.UK
Advancing support for endometriosis and menstrual wellbeing GOV.UK
Published: Feb. 27, 2026, 3:11 p.m.
Bindi Irwin Issues Desperate Plea After Emergency Health Scare - AOL.com
Bindi Irwin Issues Desperate Plea After Emergency Health Scare AOL.com
Published: Feb. 27, 2026, 3:08 p.m.
Get the iRobot Roomba 104 for $70 less at Amazon - Mashable
Get the iRobot Roomba 104 for $70 less at Amazon Mashable
Published: Feb. 27, 2026, 3 p.m.
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView
Published: Feb. 27, 2026, 2:50 p.m.
13 Years After Diagnosis, I Still Feel Unprotected As An Endometriosis Sufferer - HuffPost UK
13 Years After Diagnosis, I Still Feel Unprotected As An Endometriosis Sufferer HuffPost UK
Published: Feb. 27, 2026, 2:48 p.m.
GnRH Receptor Antagonists Market Size to Hit USD 5.25 Billion by 2035 - Precedence Research
GnRH Receptor Antagonists Market Size to Hit USD 5.25 Billion by 2035 Precedence Research
Published: Feb. 27, 2026, 2:45 p.m.
Acrivon Therapeutics hosts webcast on ACR-368 trial at ESGO Congress - Investing.com
Acrivon Therapeutics hosts webcast on ACR-368 trial at ESGO Congress Investing.com
Published: Feb. 27, 2026, 2:18 p.m.
Acrivon (NASDAQ: ACRV) shows ACR-368 activity in endometrial cancer - Stock Titan
Acrivon (NASDAQ: ACRV) shows ACR-368 activity in endometrial cancer Stock Titan
Published: Feb. 27, 2026, 2 p.m.
Link copied to clipboard!